Table 2 Glomerular, tubular and intestitial lesions in 19 dogs with pyometra (P1–P19) and 13 control dogs (C1 – C13)
Dog no. | Available no. of glomeruli | Glomerular lesions | Tubular lesions | Interstitial lesions | ||
|---|---|---|---|---|---|---|
Sclerosis | Fibrosis | Tubular atrophy | Inflammatory cellular infiltration | Fibrosis | ||
P1 | 10 | 1 | 1 | 1 | 1 | 1 |
P2 | 22 | 0 | 0 | 2 | 0 | 0 |
P3 | 17 | 0 | 0 | 0 | 1 | 1 |
P4 | 14 | 0 | 1 | 1 | 1 | 1 |
P5 | 19 | 0 | 0 | 0 | 1 | 1 |
P6 | 17 | 0 | 0 | 0* | 1 | 0 |
P7 | 34 | 0 | 0 | 0 | 1** | 1 |
P8 | 29 | 0 | 0 | 1 | 1 | 1 |
P9 | 10 | 0 | 0 | 0 | 0 | 1 |
P10 | 21 | 2 | 2 | 3 | 0 | 3 |
P11 | 18 | 1 | 1 | 0 | 1 | 1 |
P12 | 10 | 1 | 0 | 2 | 0 | 1 |
P13 | 8 | 0 | 0 | 2 | 0 | 1 |
P14 | 37 | 1 | 0 | 0 | 0 | 0 |
P15 | 21 | 2 | 1 | 2 | 1 | 1 |
P16 | 6 | 1 | 1 | 2 | 0 | 2 |
P17 | 38 | 0 | 1 | 1 | 1** | 1 |
P18 | 5 | 0 | 1 | 1 | 0 | 1 |
P19 | 5 | 0 | 0 | 1 | 0 | 1*** |
C1 | a.s. | 0 | 1 | 0 | 0 | 0 |
C2 | a.s. | 1 | 2 | 0 | 0 | 1 |
C3 | a.s. | 0 | 1 | 0* | 0 | 0 |
C4 | a.s. | 1 | 2 | 0 | 0 | 0 |
C5 | a.s. | 0 | 1 | 0* | 0 | 0 |
C6 | a.s. | 0 | 2 | 2 | 2 | 3 |
C7 | a.s. | 1 | 0 | 0 | 0 | 0 |
C8 | a.s. | 2† | 1 | 1 | 0 | 1 |
C9 | a.s. | 1 | 0 | 0 | 0 | 0 |
C10 | a.s. | 1 | 0 | 0 | 0 | 0 |
C11 | a.s. | 0 | 1 | 0 | 0 | 1 |
C12 | a.s. | 1 | 1 | 0 | 0 | 0 |
C13 | a.s. | 0 | 0 | 0 | 0 | 0 |